NCT05338593View on ClinicalTrials.gov

Therapy and Outcome of Prolonged Veno-venous ECMO Therapy of Critically Ill ARDS Patients.

CompletedOBSERVATIONAL

Enrollment

100

Participants

Timeline

Start Date

May 1, 2022

Primary Completion Date

May 1, 2023

Study Completion Date

May 15, 2023

Conditions

Extracorporeal Membrane Oxygenation ComplicationOutcome, Fatal

Interventions

OTHER

Outcome

Mortality rate of prolonged therapy.

Trial Locations (1)

60590

University Hospital Frankfurt, Frankfurt am Main

Sponsors

Lead Sponsor

Goethe University

All Listed Sponsors

lead

Goethe University

OTHER

NCT05338593 - Therapy and Outcome of Prolonged Veno-venous ECMO Therapy of Critically Ill ARDS Patients. | Biotech Hunter | Biotech Hunter